Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Akcea Therapeutics Inc (NQ: AKCA )

18.17 USD UNCHANGED
Last Price Updated: 5:44 PM EDT, Oct 9, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Akcea Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Benzinga's Top Upgrades, Downgrades For September 1, 2020
Upgrades For Qualcomm Inc (NASDAQ: QCOM), Wells Fargo upgraded the previous rating of Underweight to the current rating ... 
Tags QCOM MUR GLUU
From Benzinga
10 Biggest Price Target Changes For Tuesday
Goldman Sachs raised the price target for Zoom Video Communications Inc (NASDAQ: ZM) from $187 to $402. Zoom Video shares rose 30% ... 
Tags ZEN Price Target Changes Market News
From Benzinga
60 Biggest Movers From Yesterday
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares jumped 171.6% to close at $34.22 on Monday after Nestle SA agreed to ... 
Tags VRAY BIGC Movers From Yesterday
From Benzinga
Why Akcea Therapeutics Stock Skyrocketed Today
The biotech is being acquired by its largest shareholder. 
Tags IONS Market News AKCA
From Motley Fool
Noteworthy Monday Option Activity: AKCA, ACM, GME
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Akcea Therapeutics Inc (AKCA), where a total volume of 4,572 contracts has been... 
Tags Stocks
From Market News Video
Mid-Afternoon Market Update: Nasdaq Rises Over 100 Points; Regis Shares Drop After Q4 Results
Toward the end of trading Monday, the Dow traded down 0.72% to 28446.24 while the NASDAQ rose 1% to 11,812.92. The S&P also rose, ... 
Tags ATOM Market News ACST
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at ... 
Tags ACST ADTX IGC
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares climbed 171.5% to $34.21 after Nestle SA agreed to acquire the company at ... 
Tags UTSI SHLO KIN
From Benzinga
Mid-Day Market Update: Akcea Therapeutics Jumps Following Acquisition News; Acasti Pharma Shares Plummet
Midway through trading Monday, the Dow traded down 0.94% to 28385.03 while the NASDAQ rose 0.23% to 11722.14. The S&P also fell, ... 
Tags SHLO News GMW
From Benzinga
Akcea Therapeutics Rallies After Majority Owner Ionis Agrees To Buy Remaining Stake
Akcea Therapeutics Inc (NASDAQ: AKCA) shares wererallying strongly Monday following a buyout deal. The Ionis, Akcea Deal ... 
Tags Trading Ideas Biotech News
From Benzinga
Mid-Morning Market Update: Markets Mostly Lower; Nestlé To Acquire Aimmune Therapeutics
Following the market opening Monday, the Dow traded down 0.60% to 28483.09 while the NASDAQ rose 0.26% to 11,725.76. The S&P also ... 
Tags GME Pre/Market Outlook Market News
From Benzinga
Looking Into Akcea Therapeutics's Return On Capital Employed
During Q2, Akcea Therapeutics's (NASDAQ: AKCA) reported sales totaled $22.38 million. Despite a 12.89% in earnings, the company ... 
Tags General Benzinga Health Care
From Benzinga
38 Stocks Moving in Monday's Pre-Market Session
Gainers Aimmune Therapeutics, Inc (NASDAQ: AIMT) shares rose 169.8% to $34.00 in pre-market trading after Nestle SA agreed to ... 
Tags LEDS PSV HJLI
From Benzinga
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
After seeing some strength earlier on, biotech stocks came under pressure in the week ended Aug. 21. With the earnings season tapering ... 
Tags ENTA VKTX EDAP
From Benzinga
Akcea Therapeutics, Inc. (AKCA) Q2 2020 Earnings Call Transcript
AKCA earnings call for the period ending June 30, 2020. 
Tags Market News AKCA
From Motley Fool
The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) ABIOMED, Inc. (NASDAQ: ABMD) ALX Oncology Holdings Inc ... 
Tags NUVA INCY AMRN
From Benzinga
Analysts Expect VB Will Reach $167
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical ... 
Tags NBY DRNA ZIOP
From Benzinga
Got $3,000? Here Are 3 Great Biotech Stocks to Buy Right Now
One big biotech and two small biotechs especially stand out as attractive picks. 
Tags AXSM BIIB VRTX
From Motley Fool
Akcea Therapeutics, Inc. (AKCA) Q1 2020 Earnings Call Transcript
AKCA earnings call for the period ending March 31, 2020. 
Tags AKCA Market News
From Motley Fool
The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-and-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags MYGN Earnings VCEL
From Benzinga
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ... 
Tags PGEN ENTA DVAX
From Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 2568 stocks hit new 52-week lows. Areas of Significance: Amazon.com(NASDAQ: AMZN)is the largest company ... 
Tags CONN NLSN PETQ
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, various companies made new 52-week lows. Intriguing Points: Facebook(NASDAQ: ... 
Tags PBIP IDT CHEF
From Benzinga
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ABBV TLGT TFFP
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 690 stocks hit new 52-week lows. Intriguing Points: Boeing(NYSE: BA)was the ... 
Tags XTLB FEIM PLAY
From Benzinga
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags JNJ UBX PGEN
From Benzinga
JKK's Holdings Imply 21% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Akcea Therapeutics, Inc. (AKCA) Q4 2019 Earnings Call Transcript
AKCA earnings call for the period ending December 31, 2019. 
Tags Market News AKCA
From Motley Fool
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Top Stories MYGN ELGX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.